Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | VARI, VAI, VAEI, AND VAIGS SHARE COMMON MANAGEMENT. DAVID VAN ANDEL, DR. JANA HALL AND TIMOTHY MYERS ARE ALSO OFFICERS OF VAI, AND DAVID VAN ANDEL AND TIMOTHY MYERS ARE OFFICERS OF VAEI AND VAIGS. THOMAS CURRAN JR. IS ALSO AN OFFICER OF VAIGS. GERALD CALLAHAN AND THOMAS CURRAN JR. ARE KEY EMPLOYEES OF VAI AND VAEI. |
| FORM 990, PART VI, SECTION A, LINE 2 | BUSINESS RELATIONSHIP: DAVID VAN ANDEL, GERALD CALLAHAN |
| FORM 990, PART VI, SECTION A, LINE 7A | THE TRUSTEES OF VAN ANDEL INSTITUTE HAVE THE AUTHORITY TO ELECT ONE OR MORE MEMBERS OF VARI'S GOVERNING BODY. |
| FORM 990, PART VI, SECTION B, LINE 11B | FOLLOWING COMPLETION OF THE FINANCIAL STATEMENT AUDIT, THE FORM 990 IS PREPARED AND REVIEWED BY MANAGEMENT. IT IS THEN CIRCULATED TO THE FULL BOARD PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | VARI HAS WRITTEN CONFLICT OF INTEREST ("COI") POLICIES AND PROCEDURES WHICH ADMINISTER AND ENFORCE A PROCESS TO IDENTIFY, EVALUATE, AND MANAGE POTENTIAL CONFLICTS OF INTEREST. THESE POLICIES HAVE BEEN APPROVED BY THE BOARD OF TRUSTEES. VAI ADMINISTERS COI POLICIES AND PROCEDURES THROUGH TWO STANDING COMMITTEES: THE CONFLICTS COMMITTEE ("CC") AND THE INSTITUTIONAL COI COMMITTEE ("ICOIC"). COI POLICIES AND PROCEDURES APPLY TO AND SERVE AS A GUIDE FOR EVERYONE IN THE ORGANIZATION. IN PARTICULAR, THEY PROVIDE A USEFUL RESOURCE FOR DEVELOPING ACTIVITIES OR RELATIONSHIPS WITH OUTSIDE ENTITIES OR PERSONS, AND ESTABLISH A PROCESS FOR COMMITTEES TO REVIEW AND MANAGE POTENTIAL CONFLICTS OF INTEREST AS THEY MAY ARISE. THE CC AND ICOIC ARE CHAIRED BY THE GENERAL COUNSEL. THE CC REQUIRES ANNUAL AND UPDATED DISCLOSURES BY COVERED PERSONS AND REVIEWS AND APPROVES MANAGEMENT PLANS. ICOIC POLICIES AND PROCEDURES SERVE AS A GUIDE FOR BOARDS OF TRUSTEES AND SENIOR EXECUTIVES. IN THE EVENT A POTENTIAL COI ARISES AT THE BOARD OR SENIOR EXECUTIVE LEVEL, THE ICOIC MEETS TO REVIEW AND DETERMINE HOW TO MANAGE SUCH A POTENTIAL CONFLICT OF INTEREST IN ACCORDANCE WITH THE COI POLICIES AND PROCEDURES. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA FROM AN EXPERT THIRD PARTY IS OBTAINED AND REVIEWED BY THE INDEPENDENT, JOINT COMPENSATION COMMITTEE OF VAN ANDEL RESEARCH INSTITUTE AND RELATED ORGANIZATIONS TO DETERMINE APPROPRIATE COMPENSATION FOR THE CEO, EXECUTIVE MANAGEMENT OFFICIALS, OFFICERS, AND KEY EMPLOYEES, ON BEHALF OF VAN ANDEL RESEARCH INSTITUTE. |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL DOCUMENTS REQUIRED TO BE MADE AVAILABLE TO THE PUBLIC ARE AVAILABLE FOR PUBLIC INSPECTION UPON WRITTEN REQUEST. |
| FORM 990, PART III, LINE 2 | VAN ANDEL RESEARCH INSTITUTE (VARI) IS DEDICATED TO DETERMINING THE EPIGENETIC, GENETIC, MOLECULAR, METABOLIC, AND CELLULAR ORIGINS OF CANCER, PARKINSON'S DISEASE, AND OTHER DISORDERS AND TO TRANSLATING THOSE FINDINGS INTO EFFECTIVE THERAPIES. THE INSTITUTE'S SCIENTISTS WORK IN ONSITE LABORATORIES AND PARTICIPATE IN COLLABORATIONS THAT SPAN THE GLOBE. WITH EPIGENETICS AS ITS COMMON THREAD, THE INSTITUTE IS ORGANIZED INTO FIVE DEPARTMENTS: EPIGENETICS, NEURODEGENERATIVE SCIENCE, CELL BIOLOGY, METABOLISM AND NUTRITIONAL PROGRAMMING, AND STRUCTURAL BIOLOGY. THE INSTITUTE'S LABS ARE SUPPORTED BY AN OUTSTANDING CORE TECHNOLOGIES AND SERVICES GROUP, WHICH PROVIDES A VIVARIUM, A BIOREPOSITORY, AND VALUABLE ONSITE CAPABILITIES IN IMAGING, PATHOLOGY, BIOINFORMATICS AND BIOSTATISTICS, GENOMICS, FLOW CYTOMETRY, MASS SPECTROMETRY, TRANSGENICS, AND CRYO-ELECTRON MICROSCOPY. IN ADDITION TO BASIC RESEARCH, THE INSTITUTE PARTICIPATES IN COLLABORATIVE EFFORTS TO SUPPORT CLINICAL TRIALS IN CANCER AND PARKINSON'S DISEASE. IN 2024, VARI SCIENTISTS PUBLISHED 122 ARTICLES IN PEER-REVIEWED JOURNALS SUCH AS CELL, CELL METABOLISM, MOLECULAR PSYCHIATRY, NATURE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, SCIENCE, SCIENCE ADVANCES, GENES & DEVELOPMENT, JOURNAL OF CLINICAL INVESTIGATION, JOURNAL OF EXPERIMENTAL MEDICINE, AND NUCLEIC ACIDS RESEARCH, AMONG OTHERS. |
| FORM 990, PART III, LINE 4A | LINE 4A - PROGRAM SERVICE ACTIVITY #1 DEPARTMENT OF EPIGENETICS AS OF NOVEMBER 2024, THE DEPARTMENT OF EPIGENETICS, LED BY CHAIR DR. J. ANDREW POSPISILIK, COMPRISED 12 LABORATORIES AND ONE DIRECTOR'S SCHOLAR THAT SEEK TO UNDERSTAND HOW EPIGENETIC CHANGES EITHER PROTECT US FROM OR PREDISPOSE US TO DISEASES SUCH AS CANCER, PARKINSON'S, AND METABOLIC DISORDERS. BY INVESTIGATING THE EPIGENETIC PROCESSES THAT FINE-TUNE DNA, THE DEPARTMENT'S SCIENTISTS AIM TO PINPOINT THE ORIGINS OF THESE DISEASES AND DETERMINE HOW THEY ARE IMPACTED BY OUR PAST AND PRESENT, AND HOW THEY INFLUENCE FUTURE GENERATIONS. IN THIS FISCAL YEAR, RESEARCHERS AND TRAINEES WITHIN THE DEPARTMENT EARNED NEW AWARDS FROM THE NATIONAL INSTITUTES OF HEALTH. |
| FORM 990, PART III, LINE 4B | LINE 4B - PROGRAM SERVICE ACTIVITY #2 DEPARTMENT OF NEURODEGENERATIVE SCIENCE AS OF NOVEMBER 2024, THE DEPARTMENT OF NEURODEGENERATIVE SCIENCE, CHAIRED BY DR. DARREN MOORE, COMPRISED SEVEN LABORATORIES THAT INVESTIGATE THE COMPLEX FACTORS THAT GIVE RISE TO NEURODEGENERATIVE AND PSYCHIATRIC DISORDERS, INCLUDING GENETICS, EPIGENETICS, AGING, INFLAMMATION, THE STRUCTURE OF THE BRAIN, AND THE ROLES OF THE GUT AND IMMUNE SYSTEM. BY LEVERAGING DISCOVERIES MADE IN THE INSTITUTE'S LABS AND COLLABORATING WITH RESEARCHERS AROUND THE WORLD, SCIENTISTS IN THE DEPARTMENT ARE WORKING TO TRANSLATE BREAKTHROUGHS INTO LIFE-CHANGING NEW TREATMENTS FOR PARKINSON'S, ALZHEIMER'S AND RELATED DEMENTIAS, AND DEPRESSION. IN THIS FISCAL YEAR, A TRAINEE WITHIN THE DEPARTMENT EARNED A NEW AWARD FROM THE NATIONAL INSTITUTES OF HEALTH. A SUBAWARD WITH A PRIME SPONSOR OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH WAS RECEIVED FROM NORTHWESTERN UNIVERSITY. |
| FORM 990, PART III, LINE 4C | LINE 4C - PROGRAM SERVICE ACTIVITY #3 DEPARTMENT OF METABOLISM AND NUTRITIONAL PROGRAMMING AS OF NOVEMBER 2024, THE DEPARTMENT OF METABOLISM AND NUTRITIONAL PROGRAMMING, CHAIRED BY DR. RUSSELL JONES, COMPRISED SIX LABORATORIES THAT EXPLORE THE INTRICATE MECHANICS OF CELLULAR METABOLISM AND ITS IMPLICATIONS FOR HEALTH AND DISEASE. USING CUTTING-EDGE TECHNIQUES, THEY INVESTIGATE METABOLISM'S INTERACTION WITH OTHER CRITICAL SYSTEMS, SUCH AS THE IMMUNE SYSTEM, AND ARE REVEALING HOW ENVIRONMENTAL EXPOSURES AND METABOLIC DYSFUNCTION CONTRIBUTE TO COMPLEX DISEASES SUCH AS DIABETES, AUTOIMMUNITY, CANCER, AND NEURODEGENERATION. THEY ALSO PARSE THE RIPPLE EFFECT THAT NUTRITION MAY HAVE THROUGH THE GENERATIONS BY EXPLORING HOW DIET COULD LAY THE EPIGENETIC FOUNDATIONS FOR HEALTH. IN THIS FISCAL YEAR, RESEARCHERS AND TRAINEES WITHIN THE DEPARTMENT EARNED NEW AWARDS FROM THE NATIONAL INSTITUTES OF HEALTH AND THE NATIONAL SCIENCE FOUNDATION. |
| FORM 990, PART III, LINE 4D | LINE 4D - OTHER PROGRAM SERVICES DEPARTMENT OF CELL BIOLOGY AS OF NOVEMBER 2024, THE DEPARTMENT OF CELL BIOLOGY, LED BY INTERIM CHAIR DR. YVONNE FONDUFE-MITTENDORF, COMPRISED SIX LABS THAT PURSUE FUNDAMENTAL RESEARCH TO UNDERSTAND HOW CELLS GROW, COMMUNICATE, SURVIVE, ASSEMBLE INTO TISSUES AND ORGANS, RESPOND TO THE ENVIRONMENT, AND CHANGE WITH AGE. THIS TRANSFORMATIVE WORK AIMS TO YIELD NEW DIAGNOSTIC AND TREATMENT STRATEGIES TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE WITH CANCER, BONE DISEASES, AND RARE DISORDERS. ONE FACULTY MEMBER HOLDS AN APPOINTMENT AS DIRECTOR OF THE INSTITUTE'S CORE TECHNOLOGIES AND SERVICES. DR. FONDUFE-MITTENDORF HOLDS A PRIMARY APPOINTMENT IN THE DEPARTMENT OF EPIGENETICS. IN THIS FISCAL YEAR, RESEARCHERS WITHIN THE DEPARTMENT EARNED NEW AWARDS FROM THE NATIONAL INSTITUTES OF HEALTH AND THE AMERICAN CANCER SOCIETY. A SUBAWARD WITH A PRIME SPONSOR OF THE NATIONAL INSTITUTES OF HEALTH WAS RECEIVED FROM THE UNIVERSITY OF PITTSBURGH. DEPARTMENT OF STRUCTURAL BIOLOGY AS OF NOVEMBER 2024, THE DEPARTMENT OF STRUCTURAL BIOLOGY, CHAIRED BY DR. HUILIN LI, COMPRISED SIX LABORATORIES THAT HARNESS THE POWER OF CRYO-ELECTRON MICROSCOPY (CRYO-EM) AND OTHER TECHNIQUES TO VISUALIZE MOLECULES, COMPLEXES, AND STRUCTURES THAT SERVE AS THE FOUNDATION FOR HEALTH AND DISEASE. THESE MOLECULES MAY SERVE AS DRUG TARGETS FOR CANCER, NEUROLOGICAL DISORDERS, METABOLIC DISEASES, INFECTIOUS DISEASES, AND MORE. DEPARTMENT SCIENTISTS HAVE INTERESTS IN DNA REPLICATION, CELLULAR SIGNALING, RNA BIOLOGY, NEURODEGENERATION, IMMUNOLOGY, AND EPIGENETICS. IN THIS FISCAL YEAR, RESEARCHERS AND TRAINEES WITHIN THE DEPARTMENT EARNED NEW AWARDS FROM THE NATIONAL INSTITUTES OF HEALTH AND AMERICAN HEART ASSOCIATION. SUBAWARDS WITH A PRIME SPONSOR OF THE NATIONAL INSTITUTES OF HEALTH WERE RECEIVED FROM CORNELL UNIVERSITY AND CORIELL INSTITUTE FOR MEDICAL RESEARCH. CLINICAL COLLABORATIONS THE VAN ANDEL INSTITUTE-STAND UP TO CANCER EPIGENETICS DREAM TEAM, LED BY DR. PETER A. JONES AND DR. STEPHEN BAYLIN, CONTINUES TO FOSTER COLLABORATION TOWARD DEVELOPMENT OF NEW COMBINATION THERAPIES FOR CANCER BY MOVING THESE PROMISING THERAPIES INTO CLINICAL TRIALS. THE TEAM FOCUSES ON EPIGENETIC MECHANISMS IN CELLS, WHICH HELP CONTROL WHETHER GENES ARE SWITCHED "ON OR "OFF" WITHOUT CHANGING THE DNA SEQUENCE ITSELF. INTERNATIONAL LINKED CLINICAL TRIALS IS A PROGRAM THAT IDENTIFIES POTENTIAL NEW THERAPIES THAT MAY SLOW OR STOP PARKINSON'S PROGRESSION FROM MEDICATIONS DEVELOPED OR APPROVED TO TREAT OTHER CONDITIONS. THE PROGRAM IS SPEARHEADED BY CURE PARKINSON'S IN COLLABORATION WITH THE INSTITUTE. IT AIMS TO REDUCE THE TIME IT TAKES FOR A POTENTIAL TREATMENT TO MOVE FROM THE LAB INTO CLINICAL TRIALS AND, ULTIMATELY, TO IMPLEMENTATION IN THE CLINIC. DR. DARREN MOORE REPRESENTS VAI ON THE ILCT COMMITTEE. |
| FORM 990, PART IX, COLUMN D | FUNDRAISING EXPENSES AT VARI WERE INCURRED TO SUPPORT THE MISSION OF THE RESEARCH INSTITUTE THROUGH DONOR SOLICITATION, GRANT SOLICITATION AND EXTRAMURAL PROPOSAL PREPARATION. |
| Software ID: | |
| Software Version: |